Resources

Explore our online resource catalog to discover publications, presentations, tools, and related resources for global health practitioners, decision-makers, advocates, and more.

All resources

Read our latest

2342 Result s
2342 Result s
    Date
    From
    To
  1. The COVID-19 pandemic has highlighted the need for oxygen and other respiratory care supplies and equipment around the globe.In response, PATH conducted a biomedical equipment survey in 29 designated COVID-19 treatment centers across 13 of 14 regions in Senegal. The purpose of this survey was to quantify existing oxygen delivery and production equipment, consumables for administering oxygen therapy, bed capacity, and facility infrastructure characteristics that are relevant to providing respiratory care. The results indicated that intensive care unit bed capacity was a key constraining factor to oxygen therapy, and there was significant scarcity of oxygen delivery equipment across Senegal, with available oxygen equipment often totaling far less than the number of reported beds.This report summarizes observations from the collected data and is intended to help global and national stakeholders understand COVID-19 treatment capacity in Senegal.
    Published: April 2021
    Resource Page
    Report
  2. The Global Fund Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.The 2020-2021 Annual Report presents findings from the grant cycle analysis which examined what, when, why, and how grants approved through the New Funding Model 2 (NFM2; 2017-2019 funding cycle) changed over time, including significant factors that influenced the implementation of changes to the original grant. Additionally, the report includes findings on how the NFM3 (2020-2022 funding cycle) grant design process was informed by lessons from NFM2.The 2021 Extension Phase Report presents findings from a three-month extension of the PCE that focused on a deeper analysis of several areas within the grant cycle analysis, including: grant revision and lessons learnt from the Global Fund’s response to COVID-19, investments in health systems support and health systems strengthening, uptake of new RSSH coverage indicators, and drivers of budgetary shifts in RSSH and equity-related investments during NFM3 grant making.
    Published: March 2021
    Resource Page
    Report
  3. The Global Fund Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.The 2020-2021 Annual Report presents findings from the grant cycle analysis which examined what, when, why, and how grants approved through the New Funding Model 2 (NFM2; 2017-2019 funding cycle) changed over time, including significant factors that influenced the implementation of changes to the original grant. Additionally, the report includes findings on how the NFM3 (2020-2022 funding cycle) grant design process was informed by lessons from NFM2.The 2021 Extension Phase Report presents findings from a three-month extension of the PCE that focused on a deeper analysis of several areas within the grant cycle analysis, including: grant revision and lessons learnt from the Global Fund’s response to COVID-19, investments in health systems support and health systems strengthening, uptake of new RSSH coverage indicators, and drivers of budgetary shifts in RSSH and equity-related investments during NFM3 grant making.
    Published: March 2021
    Resource Page
    Report
  4. India is an emerging economy with a population of more than 1.3 billion people. Over the past several decades the country has experienced rapid development and there has been a marked shift in its disease pattern. Given the rise in the noncommunicable disease (NCD) burden in India, PATH and Access Accelerated undertook an NCD landscaping study to identify key stakeholders as well as barriers and facilitators in the provision of NCD care. PATH developed priority areas of investment based on expert interviews, local prevalence data, and a review of policies and related literature exposing barriers and facilitators to access to quality NCD care.
    Published: March 2021
    Resource Page
    Report
  5. The MAP Center of Excellence has produced two business case analyses for measles-rubella (MR) vaccine and contraceptive MAPs to inform future investment and development. Please send any feedback or comments on the documents to maps@path.org
    Published: March 2021
    Resource Page
    Brief, Report